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RheolytlcThrombectomyversusSurgical
EmbolectomyForTrastmentofThromboeed
HemodislysiSA-VGraftaandPeripheralVessels:
ReeultaFromA Prospective,Multi-CenterStudy
S.R. Ramee, for the Possis Peripheral AngioJe~ Study Investigators.
Ochsner Clinic, New Orleans, LA, USA
We have previously demonstrated the safety and efficacy of AngioJet@
catheter in removing intra-arterial thrombus by rheolylic ttrrombectomy (RT).
The aim of the phase II study wee to compare the efficacy of RT to Fogarly
balloon embolactomy (FBE) in treatment of thromboaad hemodialysis A-V
grafts (n = 118) and peripheral vessels (n = 19). The study included 136
pte (137 lesions) prospectively randomized to RT (n = 75) or FBE (n = 62).
Quantitative anglogrephy was performed in a core lab by automated edge
detection technique. Remeasured angiographic success(reducedthrombus
burden), clinical succeas (restoration of blood flow without major complica-
tion), and thrombus burden (ideal vessel area - meaaurad lumen areaAdeal
area x 100). Freedom from adverse events (rethromboais, restenoeis, or
repeat percutaneous or surgical intervention) at 30 and 180 days was also
compared.
Results:
RT(n =75) FBE (n = 62) p value
Angiographicsuooaee(cors lab) 65 (97%) 40 (95%) 0.64
ClinicalSuccess 55 (79%) 51 (64%) 0.51
Pre Thrvmbus Burden(OA) 99 rt 6 96& 10 063
ResidualThrombusBurden(%) 19• 22 13 *21 0.16
Freedom from Events 30 Days 53* 13 5s i 13 0.54
180 Days 16+ 13 26 i 14 034
Conclusions: Mechanical thrombectomy using t A nc a
p r oa a l tp e rt ef t ro a c
t h rh e mA g ra p ev ea i e q
e f fa s uF ob ae m b
m1008165 PercutaneousHydrodynamicThrombactomyWiththe Uaaof theHydrolyeerSystem
M. Henry, M. Amor, 1.Henry, J.M. Porte, O. Tricoohe, E. Le Borgne. UC(2,
Polyclhrique Essey-/es-Nanc& France
Purpose: Topreaent our clinical experience with a new mechanical hydro-
dynamic thrombactomy aystem (Hydrolyaar), using the Venturi effect. This
device waa applied for thrombus removal in native arferiea, arterial grafts,
venous aystem and pulmonary arteries.
Materia/andkfethods: The Hydrolyeer,a 7 F,double lumen, over the wire
catheter has been used in 50 patienta (M: 29, F: 21), mean age: 86.2 +
13.1 yre (40-90), with recent thrombosis. Ocoluaion time ranged from 1 to
30 daye (mean 8.2 + 7.3 daye), thrombus length, from 4 to 35 cm (mean:
17.7 + 10.2 cm). Thrombus’ location: native arteries (n = 35: femoropop: 28,
iliac: 7), arferfal grafts (n= 9), superior vena cava (n = 2), axillary vein (n =
2), pulmonary artery (n= 2). Approach waya: arterial femoral antegrade (n =
22), retrograde (n =7), oontralateral (n = 14), popliteal arterial (n = 1),venous
femoral (n= 5), venoue humeral (n = 1).
Resu/fa:Tachnical auocesain 41 pte (8WO): native arteries (27/35) (77%),
afterial graft (S/9) (89%), pulmorany attery (2/2), euperior vena cava (2/2),
axillary vein (2/2). Thrombua eatimatsd angiographicaily to be removed by
the Hydroiyser: 72.5 * 22%. Adjunctive therapy: angioplaaty (n = 38, 19
immediate stents implantations), thromboaapiretion (n = 17), reduced time
fibrinolysis (n = 11). 1 complication: distal emboliam cured by thromboaapi-
ration. In 9 pta the procedure failed, requiring aurgery (bypasa or Fogarty).
At 30 days, 37 vesaela remained patent (74%).
Conclusion: The Hydmlyser syetem is a promising concept for percuta-
neous thrombeotomy.’lt ie quick, reiiable, efficient and can bean alternative
to thrombolyeia and aurgioal thrombectomy.
T uM 1 1 N p.m.
AnaheimConventionCenter,Hall E
P rH 1 p p
11009-1291 praeef’vedLeftVentrkNlarFunctloninthePost
MyocardialInfarctionPatientis Predictedbya
SimpleClinicalRule
K. Tobin, K. Eagle, D. Karavite, W,W. O’Neill, C.L. Grines. kVi//iarn
Beaumont Hospital, Royal Oak, Ml, USA, Univ. QfMichigan Heart Care
Outcomes Assessment Team,Ann Arbofi Ml, USA
In retrospaetive studiea we have shown that if a myocardial infarction (Ml)
patient meets 4 clinical and/or ECG criteria, ejection fraction (EF) la > 40%
with a positive predictive value (PPV) of 0.88 to 0.96. Theae criteria are (1)
no histoty of CHF, (2) ECG without LBBB, pacing, or LVH with atrain, (3)
index Mi not an anterior with Q-wave or ST elevation, (4) no prior Q-wave
Ml outaide current Ml zone, In this study we eought to validate the clinical
rule in a seletied cohort of 385 acute Ml patienta prospectively enrolled in
the PAMI-I reperfusion trial and to determine whether timing of post-Ml EF
assessment affected the accuracy of the clinical rule. All patienta had z
one EF measurement (contrast ventriculography or gatad blood pool acan)
within the first 24 hours of Ml and 219 had a follow-up gated blood pool scan
at 6 weeka. 3S5 patients were atudied; average age 80 yeara, 74°A were
male, 48% were treated with primary pTCA and 54% with TPA, and 61%
of patienta had anterior ML The clinical rule predicted 233 patienta would
have an acute EF ? 40%, and 217 were correctly classified; a PPV of 0.93.
Among 219 patients who also had a late gatad blood pool acan, the clinical
rule predicted that 141 patients would have an LVEF ? 40%, and 132 were
correctly classified; a PPV of 0.94. Conclusion: This study demonstrate
that the routine application of 4 clinical and ECG criteria are able to predict
acute and 6 week LVEF with a PPV of 0.93. These data suggest that among
patients undergoing acute repeflusion, if.is conceivable that as many ee60%
could forgo routine LVEF assessment, resulting in a substantial cost aaving.
-[ APopulatiOnSuf’veyOfthehIcid..ceand
Aetiologyof HesrtFailure
M.R. Cowie, H. Penston, D.A. Wood, A. Coata, S. Thompeon,
P.A. Poole-Wilson, G.C. Sutton. Cardiac Madlcirre, Nariona/Hear?& Lung
Institute, London, UK, /mperia/ Co//ege of Medicine, London, UK, Hi//in@rr
Hospital, Uxbridga, London, UK
The object of this community aurvey was to describe the contemporary inci-
dence and aetiology of hearf failure. New cases of heari failure presenting to
the 81 general practitioners (GP’s) and a diatrict general hospital serving a
population of 151000 were identified prospectively over 15 montha. Caees
were identified through a daily open-acceaa hearl failure clinic to which GP’a
referred all new cases of suspected hearf failure and from hoapital admia-
aions. Following a atandardiaed interview, phyaical examination, ECG, CXR
and achocardiogram all cases were reviewed by a panel of 3 cardiologists
who determined whether the definition of heart failure was met, and aetiology.
170 new caaea of hearl failure were identified in the dietricf with a median
age at presentation of 75 yeare. The crude incidence rate was 0.9 cases per
1000 population per annum, riaing from 0.2 caeea/1000/p.a. in those aged
3S-44years to 11.4 casee/1000/p.a. in thoee aged 85 yeara and over, with
a higher incidence in men than women at all ages. 35 (21%) caaea were
identified through the hearl failure clinic, the remainder being acute hospital
admission. The aetiologies were iachaemic heal diseaee (36%), hyperten-
sion (15%), atrfal fibrillation alone (6%), valve disease (6%) and other (6%).
In 29% of cases the aetiology muld not be determined from the history,
examination and above investigations. Within thia population the incidence
of heart failure risea dramatically with age, with the majority of caaee arising
in the elderly. Most caaes preeent acutely to hoapitel, and iachaemic heart
disease is the single most common aetiology.
1009-131 Characterizationof LeltVentricularEndSyatolic
StraasinYoungAdults:TheCARDIAStudy
N. Sante-Domingo, T. Kurosaki, C.L. Reid, M. Orlov, A.-M.A. Hsieh,
J.M. Gardin, for the Coronary Artery Risk Development in Young Adults
Group. Universifyof California, hvine, Orange, CA, USA
Left v ee na ( i a m o L a a
results in increased LV mass. LVESS (and LV maaa) haa been found to be a
pradictorof cardiovascular morbidity and mortality in middle aged and elderly
populations. However, the relation of LVESSto race, gender, anthropometrfc
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measurementsand epidemiologicfactorshasnot beandefinedin a young
cohort.In CARDIA(CoronaryArteryRiskDevelopmentin YoungAdults),a
multicenterNHLBlstudy,4,243menandwomenbetweentheagesof23t035
yearaoldwerestudiedwithechocardiography.LVESSwasderivedfrom2-D
directedM-mqdeeohoandsystolicBP.LVESS(adjusted)wasgreaterinmen
thanwomen(132VS103gticti, p -=0.001)and blacksthanwhites(119
vs112gm/cr#, p < 0.001).Inbivariateanalysis,LVESSwascorrelatedwith
BP,subacapularskinfoldthickness(SSFT),height,weightand pulmonary
function.In multivariateanalysis,the raceandgenderdifferencesremained
significantafteradjustmentfor bodysize,BP,and otherCVDriskfactors.
Independentpredictorsof LVESSincludedsystolicBP,SSFTandheight,but
notphysicalactivity.Overallvarianceof LVESSexplainedbythe modelsin
eachrace-sexsubgroup(R2)rangedfrom0.17to 0.23.
Conclusions:1)LVESSisgreaterinyoungmenV6BUSwomenandblacka
verauswhites;and 2) LVESSin youngaduitsis correlatedwith traditional
CVDriskfactorsandanthropometricfeatures.
m1009132 Is LeftVentricularMaceGreeterinAfricanAmericeneComperedWithWhitesin Femilies
Withs Historyof PremstureCoroneryHesti
Dieesee?
W.S.Post,B.G.Kral,T.F.Moy,J.L.Weiss,FLM.Yook,D.M.Becker,
R.S.Blumenthal.JohnsHopkinsMedicalInstitutions,Baltimore,MD,USA
Increasedleftventricularmass(LVM)hasbeenshownto be morecommon
in AfricanAmericans(AA)than in whites (W)and is a strong,independent
riskfactorfor coronaryheartdisease(CHD).To determinewhetherracial
differencesin LVMalso exist amongfamiliesat high risk for CHD,LVM
wasmeasuredin AA and W asymptomaticsiblings(SIBS,ages30-59) of
patientewithprematureCFfDusingM-modeachoeardlographyandindexed
to heightand to bodysurfacearea (BSA).No significantraciaidifferences
wereobsewadfor LVMindexadto heightor BSAin maleor femaleSIBS.
Usingseparatemultiplelinearregressionanalysesinmenandwomen,body
mass index (BMI) (p c 0.001) and systolicblood presaura(SSP)(p <
0.001)weresignificantpredictorsof LVMbutageandracewerenot.When
hypertensiveSIBSwere removedfrom these analyses,racestill did not
predictLVM.Thus,whilethereare racialdifferencesin leftventricularmass
in the generalpopulation,AfricanAmericanandwhiteSIBSat highriskfor
prematureCHDhaveeimilarLVM.
W Males AA Males W Females AA Females
(n= 144) (n =43) (n= 173) (n= 75)
Aae (veare) 46*7 45*S 45*S 47*7
- ..
BMI (@#) 27.7& 3.7 2S.6+ 5.1 27.4 &6,0
55P (mmHg)
30.6+ 7.6
134* 15 135* 14 128 i 15 135* 1s
LVMihsight(gfm) 10S &24 112 +23 92 &23 97 k 27
LVWB6A (#mz) 94* 1s 96+ 19 64+1s S5 * 22
Msan *SD
H1009133 DemogrsphlcsndCorrelatesof Five-YearChangein EchocardiogrsphjcLeftVentricular
MsssinYoungAdults:TheCARDIAStudy
J.M.Gardin,S.Gidding,P.Schreiner,D.Brunner,T.Kurosaki,H.McCreath,
H.Anton-Culver,C.Reid.Universityof California,Irvine,USA
Leftventricularmass(LVM)isknownto bea powerfulindependentpredictor
forcardiovascuiardisease(CVD)eventsinadultainthepresenceorabaence
ofclinicalhypertensionor CVD.However,littleisknownaboutthecorrelates
ofchangeinLVMinyoungadults.TheCARDIAStudyisanNHLE@ormorad
multicanterlongitudinalpopulation-basedstudyof equalnumbersof black
and whitemen and women,who wereages23 to 35 at the time of their
firstechoexamin Year5 (1990-91);halfthe cohort(2 of 4 centers)hada
repeatechoexaminYear10.Preliminaryanalyseswerepetforrnsdin 1,532
participantswho hadpairedechostudies.In bivariateanalyses,significant
(p< 0.05)predictorsof 5-yrchange(A) in 2D echodiraotedM-modeLVM
included:Year5 bodymassindex(BMI)-smeasureof obaeity+mdsystolic
BP,butnot5-yrA inthesevariables.Muitivariabieanalysesbyrace-gender
subgrouprevealeda significant(p = 0.0001)5-yr A in LVMoniy in black
women(medianincrease=5.1 gin).Furthermore,a5 kdmzincreaseinYear
5 BMIwasassociatedwitha 1.5gm increase in A LVMin blackwomen(p=
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H1009134 BiochemicalScreeningfor LeftVentricularDysfunction
T.A.McDonagh,S.D.Robb,J.J.McMurray,C.E.Monlson1,J.J.Morton,
H.Tunstall-Padoal,H.J.Dargie.cardiologyDepartment,TheWestern
InfirmaryGlasgow,Scotland,UK,1ScottishMONICAProject,Glasgow,
Scot/and,UK
Plasmaconcentrationsof N-TerminalAtriaiNatriureticPeptide(N-ANP)and
BrainNatriuraticPaptide(BNP)am knownto be raisedin patientawithCf-iF
and,Ieftventricularsystoiicdysfunction(LVD).WeinvestigatedwhetherBNP
andN-ANPwouldbe suitabiescreeningtoolsfor identifyingsubjectsin the
generalpopulationwith LVD.We studied557 men and womenagad 55-
74,.mndomlysampledfromthe NorthGlasgowPopulation.Leftventricular
functionweeassessedaohocardiographicallybya BiplaneSimpson’sRule
EjectionFraction.A LVEFof s 30%hasbe takenas LVDas it represents
a 33%reductiononthe meanvalue(47.7Yo)for subjectsfree of cardiovas-
culardiseasewithinthis population.An abnormalECGwasdefinedaathe
presenceof q waves,LBBBand ST~ wavechanges.4.8%(30/626)hada
LVEFs 30Y0,557hadplasmasampiesforBNPandN-ANPmeasured.Both
BNPand N-ANPweresignificantlyraisedin subjectswith LVD(p c 0.01)
seeTable:
N-ANP LVEF LVEF BNP LVEF LVEF(n@ml) ? 30% > 30% (rwfmi) s 30”A > m%
Median 3.2 1.8 Median 27,5 11
IQR* 2.1,5.4 1.2.2.7 IQR 21,5,34.5 5.7, 17.2
* InterquanilaRange.
A BNPconcentration> 14.5p@mlgave an 63% sensitivityand 90%
specificityfordiagnosingLVD.Itweesuperiorto N-ANP(oonc.>2.8 rig/ml):
sensitivity84%,specificity75%.Targetingtheanalysistosubjectswithanab-
normalECG(usingBNP)improvedthe aansitivilyto 92’%(specificity71%).
Plasmaconcentrationsof BNPare valuablein screeningindividual sus-
pectedof havingLVD.
]1010]Healthca~eDeliveV:Les*OnsinCorOnaV
Disease
Tuesday,March18, 1997, Noon-2:00 p.m.
Anaheim Convention Center, Hall E
PresentationHour:Noon-1 :00 p.m.
H1010135 10YearNaturalHistoryof InvssiveProceduresfor HeartDiseaseinCalifornia:19S3-1993
N.S.Kate,D.A.Maahan,D.M.Carlisle.UCLAMedicalCenterjLosAngeles,
CA,USA,RAND,SentaMonica,CA,USA
Cardiaccatheterization(CC),percutaneoustransluminalcoronaryangio-
plasty(PTCA),and heartsurgery(HS)are invasiveproceduresfor heart
disease.Theuseratesof theseproceduresandtheirimpactoncerdiovaacu-
iardisease(CVD)deathratesareunknown.WeobtainedStateof California
prfrnarydisoharge data information from the Office of Statewide Health, Plan-
ning, and Development (OSHPD) and CVD death rateafrom the Office of
Vifal Statistics and annual estimates of Caiifomiastate population (POP)from
the USCensusBureaufor 1963-1993.Forthe 10yearperiodper 100,000
population,wefound:1)POPincreased23.1%,2) CCincreased103.6%,3)
HSincreased15.7%,4)PTCAincreased306.0%,5)CVDdecreased19.4%
and6) the ratioofCCto HSandPTCAfell 18.9Y0.Wecreateda multivariate
linearregressionmodelto predictCVDdeathrates.The modelwashighly
statistioailysignificant(~ = 0.97;P < 0.0001)andshoweda declineinCVD
deathratesassociatedwithyear(p= 0.0012)andwithHSrates(p= 0.0285)
butnotaseooiatedwithPTCArates(p= 0.0775).Weconcluda:1)thegrowth
in CCwasduetothe introductionandgrowthof PTCA,2) the disproportion-
ategrowthinCCsuggeststhatappropriatenessof CC,HSandPTCAneeds
to bereevaluated.Thecost-effectivenessofthisinvasivestrategyto manage
heartdiseaseis unciear.Statewidetrackingof ratesof proceduresandtheir
costsareessentialto optimizesocietaloutmmeagivenscarceresourcae.
0.01).
In conclusion,in youngadults in the CARDIAstudy:(1) modest5-yr
(median)increaseain echoLVmassweredetectedin blackwomen,and(2)
5-yrchangesinLVmasswerereiatscftoYear5bodymassindexandeyetolic
bloodpressure.
